Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH)

Abstract

The low incidence of NASH in medical claims data corroborates the pattern of NASH underdiagnosis in clinical practice. Claims-based machine learning could facilitate the detection of patients with probable NASH for diagnostic testing and disease management.